Postoperative Delirium in Patients Undergoing Radical Cystectomy

Status Completed

Clinical Trial Summary

In this study, post-operative delirium will be measured in patients undergoing surgery for bladder resection, and associated microRNA biomarkers will be evaluated in patients considered delirious and non-delirious after surgery.

Clinical Trial Description

With voluntary participation, this study requires participants to complete a self-administered cognitive evaluation (SAGE) before surgery to assess baseline cognitive impairment and early dementia; vital signs will be documented prior to surgery. During surgery, participants will receive a standardized general anesthesia regimen as described in the protocol. Several parameters will be measured during surgery, including bispectral monitoring to measure processed EEG. After surgery, fitness for cognitive evaluation will be determined by the Richmond Agitation-Sedation Scale (RASS) scale, and then emergence delirium will be assessed using the CAM-ICU scale. Fitness for discharge from PACU will be determined by an Aldrete score of 9 or more. Postoperative pain will be assessed using the 11-point Numeric Rating Scale (NRS-11). Postoperative nausea and vomiting (PONV) level will also be documented. Postoperative Delirium (POD) assessment will be achieved by administering the memorial delirium assessment scale (MDAS) twice a day starting on day 1 through day 3 postoperatively. Pain NRS-11 score and PONV levels will also be documented at each visit. For microRNA testing, blood probes will be collected in 5mL purple top tube at surgical preadmission and post-surgery days one, two and three. Risks associated with participating in this study include normal risk associated with having surgery and general anesthesia; no greater than minimal risk is associated with blood collection. For the participant, there are no immediate anticipated benefits for participating in this study. The importance of the knowledge that is expected to result includes lower post-operative complications as a result of post-operative delirium, faster recovery, and shorter hospital stay. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03132168
Study type	Interventional
Source	Ohio State University
Contact
Status	Completed
Phase	N/A
Start date	January 10, 2018
Completion date	January 31, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06028126` - Superficial Parasternal Intercostal Plane Block in Cardiac Surgery Trial	N/A
Not yet recruiting	`NCT05877326` - Anaesthetic Depth and Short Term Delirium Post Cardiac Surgery Intervention	N/A
Terminated	`NCT00991328` - Role of Absolute Cerebral Oximetry to Prevent Neurocognitive Injury in Elderly Patients Undergoing Cardiac Surgery	Phase 3
Active, not recruiting	`NCT03785158` - MIND After Surgery	N/A
Recruiting	`NCT06236854` - Neuroimaging Risk of Postoperative Delirium
Completed	`NCT00250237` - Post-operative Haloperidol Versus Placebo for Prevention of Post-operative Delirium After Acute Hip Surgery	Phase 3
Completed	`NCT03953313` - Risk Communication About Post-operative Delirium (POD) and Post-operative Cognitive Dysfunction (POCD)
Recruiting	`NCT05887076` - Postoperative Delirium After Kidney Transplantation
Recruiting	`NCT05777187` - Mitigation of Postoperative Delirium in High-Risk Patients	N/A
Recruiting	`NCT05688449` - Effect of Epidural Analgesia on Burst Suppression	Phase 4
Completed	`NCT00791648` - Short-term Atorvastatin's Effect on Acute Kidney Injury Following Cardiac Surgery	N/A
Completed	`NCT02692300` - EEG Guidance of Anesthesia (ENGAGES-CANADA)	N/A
Completed	`NCT02325154` - Cerebral Oxygenation in Total Hip Arthroplasty Patients	N/A
Active, not recruiting	`NCT01993992` - Parental Anxiety and Its Relationship With Pediatric Patients' Post-operative Responses	N/A
Completed	`NCT00865202` - A Placebo Controlled Trial Of L-Tryptophan In Post-Operative Delirium	Phase 3
Completed	`NCT05159648` - A Study to Evaluate ICU Simulation Experience in the Cardiothoracic Surgical Population to Reduce Post-operative Delirium
Completed	`NCT01561378` - Cardiac Surgery Neuroprotection Study in Elders	Phase 2
Recruiting	`NCT06036095` - Total Intravenous Versus Inhalational Anesthesia- A Geriatric Anesthesia Study	Phase 4
Completed	`NCT03053869` - Benzodiazepine-free Anesthetic for Reduction of Delirium (B-Free)	Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.